# US 2004/0024470 A1 · Polymer re-inforced anatomically accurate bioactive protheses

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2004/0024470 A1
- Document ID: US20040024470A1
- Status: Published application
- Kind: A1
- Application number: 10/615,466
- Filed: 2003-07-08
- Published: 2004-02-05
- Earliest claimed: 1999-05-20
- Assignees: Trustees of Boston University
- Inventors: Russell A. Giordano; Benjamin M. Wu
- Web page: https://patentgrep.com/patent/US20040024470A1

## CPC

- A61F 2/2875: {Skull or cranium (A61F2/2803 takes precedence; joints for temporo-mandibular [TM] joints [TMJ] A61F2/3099)}
- A61L 27/42: having an inorganic matrix
- A61L 27/425: {of phosphorus containing material, e.g. apatite}
- A61L 27/46: with phosphorus-containing inorganic fillers
- A61F 2/2803: {for mandibular reconstruction (temporo-mandibular joints A61F2/3099; bone plates for the jaw A61B17/8071)}
- A61F 2/3094: {Designing or manufacturing processes}
- A61F 2/30942: {for designing or making customized prostheses, e.g. using templates, CT or NMR scans, finite-element analysis or CAD-CAM techniques}
- A61F 2002/2817: {Bone stimulation by chemical reactions or by osteogenic or biological products for enhancing ossification, e.g. by bone morphogenetic or morphogenic proteins [BMP] or by transforming growth factors [TGF]}
- A61F 2002/2835: {Bone graft implants for filling a bony defect or an endoprosthesis cavity, e.g. by synthetic material or biological material}
- A61F 2002/30011: {differing in porosity}
- A61F 2002/30062: {(bio)absorbable, biodegradable, bioerodable, (bio)resorbable, resorptive}
- A61F 2002/30677: {Means for introducing or releasing pharmaceutical products, e.g. antibiotics, into the body}
- A61F 2002/30968: {Sintering}
- A61F 2210/0004: bioabsorbable
- A61F 2250/0023: differing in porosity
- A61F 2310/00023: Titanium or titanium-based alloys, e.g. Ti-Ni alloys
- A61F 2310/00155: Gold or Au-based alloys
- A61F 2310/00203: containing alumina or aluminium oxide
- A61F 2310/00239: containing zirconia or zirconium oxide ZrO2
- A61F 2310/00293: containing a phosphorus-containing compound, e.g. apatite
- A61F 2310/00329: Glasses, e.g. bioglass
- B33Y 80/00: Products made by additive manufacturing
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- B33Y: ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING

## Abstract

Customized implants for use in reconstructive bone surgeries where anatomical accuracy and bone adaptation are important, such as plastic and craniomaxillofacial reconstructions. This implant comprises a porous surface layer and a tough inner core of interpenetrating phase composite. The porous surface layer enhances the biocompatibility, tissue ingrowth, and implant stability. The tough inner core improves the mechanical properties of the implant with a high fracture toughness and a low modulus. The anatomical accuracy of the implants will minimize the intra-operative manipulation required to maintain a stable host bone-implant interface.

## Claims

### Claim 1

A method for forming an implant having an inner core and an outer layer which comprises:
fabricating a preform with an open pore network;
coating at least a portion of the outer layer of the preform with a fugitive material to form an inhibition layer;
infusing selected regions of the inner core with at least one infusing media;
forming an interpenetrating phase composite in the inner core; and
removing the fugitive material from the outer layer thereby forming a porous outer layer.

### Claim 2 (depends on 1)

The method of claim 1 wherein the preform is fabricated by sintering.

### Claim 3 (depends on 2)

The method of claim 2 wherein the preform comprises a material selected from the group consisting of hydroxyapatite, bioactive glass, calcium phosphates, xenografts, allografts, autografts, isografts, ultrahigh density zirconia, zirconia toughened alumina, alumina, sapphire, titanium and gold/palladium alloys.

### Claim 4 (depends on 1)

The method of claim 1 wherein the fugitive material is selected from the group consisting of polyethylene glycol, waxes, hydrogels, acrylic latexes, and other water-soluble- or water-dispersible materials.

### Claim 5 (depends on 1)

The method of claim 1 wherein the infusion media is selected from the group consisting of acrylates including TEGDMA, MMA, Bis GMA; thermoplastics including styrene, vinyl acetate, vinyl chloride, polyethylene, PTFE, polypropylene); epoxies (polyetherketone, polyetheretherketone, polyphenylene oxide); resorbable polymers including polylactic acid, polyglycolic acid, polycaprolactone, polytrimethylene carbonate, polydioxanone, polyiminocarbonates, polyamides, polyorthoesters, polyanhydrides, polyhydroxyalkanoates, polyhydroxybutyrate); water soluble/hydrophilics including polyvinyl alcohol, PVA-based mixtures, collagen gel/poly(alpha hydroxyacids, cellulose and waxes.

### Claim 6 (depends on 5)

The method of claim 5 which comprises:
infusing the inner core with at least two infusion media.

### Claim 7 (depends on 5)

The method of claim 5 which comprises:
infusing the inner core with an inorganic material selected from the group consisting of resorbable glasses and silica.

### Claim 8 (depends on 5)

The method of claim 5 which comprises:
infusing the inner core with a material selected from the group consisting of drug molecules, growth factors, adhesion peptides, promotors and activators.

### Claim 9 (depends on 5)

The method of claim 5 which comprises:
infusing the inner core with inorganic precursors selected from the group consisting of alkoxides, metal alkoxides, silicon alkoxides, non-silicate tetravalent metal alkoxides and sol-gel organic-inorganic hybrids.

### Claim 10 (depends on 11)

The method of claim 11 which comprises:
removing the fugitive material.

### Claim 11

An implant which comprises:
a preform with an open pore network, the preform having an inner core and an outer layer, the inner core infused with a polymer which forms an interpenetrating phase composite in the inner core, the preform characterized by a flexural strength, a modulus and a fracture toughness which generally matches that of a target bone host, and at least a portion of the outer layer characterized by a defined porosity.

### Claim 12 (depends on 11)

The implant of claim 11 wherein the preform is comprised of a material selected from the group consisting of hydroxyapatite, bioactive glass, calcium phosphates, xenografts, allografts, autografts, isografts, ultrahigh density zirconia, zirconia toughened alumina, alumina, sapphire, titanium and gold/palladium alloys.

### Claim 13 (depends on 11)

The implant of claim 11 wherein the fugitive material is selected from the group consisting of polyethylene glycol, waxes, hydrogels, acrylic latexes, and other water-soluble or water-dispersible materials.

### Claim 14 (depends on 11)

The implant of claim 11 wherein the infusion media is selected from the group consisting of acrylates including TEGDMA, MMA, Bis GMA; thermoplastics including styrene, vinyl acetate, vinyl chloride, polyethylene, PTFE, polypropylene); epoxies (polyetherketone, polyetheretherketone, polyphenylene oxide); resorbable polymers including polylactic acid, polyglycolic acid, polycaprolactone, polytrimethylene carbonate, polydioxanone, polyiminocarbonates, polyamides, polyorthoesters, polyanhydrides, polyhydroxyalkanoates, polyhydroxybutyrate); water soluble/hydrophilics including polyvinyl alcohol, PVA-based mixtures, collagen gel/poly(alpha hydroxyacids, cellulose and waxes.

### Claim 15 (depends on 11)

The implant of claim 11 wherein the inner core is infused with at least two infusion media.

### Claim 16 (depends on 14)

The implant of claim 14 wherein the inner core is infused with an inorganic material selected from the group consisting of resoluble glasses and silica.

### Claim 17 (depends on 14)

The implant of claim 14 wherein the inner core is infused with a material selected from the group consisting of drug molecules, growth factors, adhesion peptides, promotors and activators.

### Claim 18 (depends on 14)

The implant of claim 14 wherein the inner core is infused with inorganic precursors selected from the group consisting of alkoxides, metal alkoxides, silicon alkoxides, non-silicate tetravalent metal alkoxides and sol-gel organic-inorganic hybrids.
